+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
BLISSGVS

Bliss GVS Pharma Share Price

₹465.65 +10.5 (2.31%)
294.62% Gain from 52W Low

31 Jul, 2026 3:53 PM (IST)

Bliss GVS Pharma live price: ₹465.65. It opened at ₹456 vs previous close ₹455; intraday high/low: ₹474/₹455. The 50 & 200 DMA stand at ₹443.60/₹303.60.

Bliss GVS Pharma Performance

  • Today's Low
  • ₹455
  • Today's High
  • ₹474
  • 52 Week Low
  • ₹118
  • 52 Week High
  • ₹553
  • Open Price₹456
  • Previous Close₹455
  • Volume299,095
  • 50 DMA₹443.60
  • 100 DMA₹379.50
  • 200 DMA₹303.60

Bliss GVS Pharma Chart

Investment Returns

  • Over 1 Month -12.12%
  • Over 3 Month + 74.17%
  • Over 6 Month + 163.48%
  • Over 1 Year + 154.22%

Smart Investing Starts Here Start SIP with Bliss GVS Pharma for Steady Growth!

Invest Now

Bliss GVS Pharma Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 38.3
  • PEG Ratio
  • 0.7
  • Market Cap Cr
  • 4,947
  • P/B Ratio
  • 4.1
  • Average True Range
  • 22.2
  • EPS
  • 12.2
  • Dividend Yield
  • 0.3
  • MACD Signal
  • -3
  • RSI
  • 47.9
  • MFI
  • 29.85

Latest Stock News Updates

Bliss GVS Pharma Ltd - 506197 - Pre-Offer Advertisement & Corrigendum to Detailed Public Statement

SBI Capital Markets Ltd ("Manager to the Open Offer") has submitted to BSE a copy of Pre-Offer Advertisement in accordance with Regulation 18(7) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, as amended, and Corrigendum to the Detailed Public Statement for the attention of the Public Shareholders of Bliss GVS Pharma Ltd ("Target Company").

Bliss GVS Pharma Ltd - 506197 - Announcement under Regulation 30 (LODR)-Cessation

Please find attached detailed intimation regarding resignation of Mr. Sachin Saboo, Senior Management Personnel of the Company, pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Bliss GVS Pharma Ltd - 506197 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Please find attached copies of the newspaper publications containing recommendation of the Committee of Independent Directors.

Bliss GVS Pharma Financials

Bliss GVS Pharma Technicals

EMA & SMA

Current Price
₹465.65
+ 10.5 (2.31%)
pointer
  • Bearish Moving Average 6
  • Bullish Moving Average 10
  • 20 Day
  • ₹473.30
  • 50 Day
  • ₹443.60
  • 100 Day
  • ₹379.50
  • 200 Day
  • ₹303.60

Resistance and Support

464.95 Pivot Speed
  • R3 493.60
  • R2 483.80
  • R1 474.70
  • S1 455.90
  • S2 446.10
  • S3 437.00

Bliss GVS Pharma Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-05-12 Audited Results & Final Dividend
2026-02-10 Quarterly Results & Interim Dividend
2025-11-06 Quarterly Results
2025-07-29 Quarterly Results
2025-05-12 Audited Results & Final Dividend
Date Purpose Remarks
2026-07-08 FINAL Rs.1.00 per share(100%)Final Dividend
2026-02-18 INTERIM Rs.0.50 per share(50%)Interim Dividend
2025-07-24 FINAL Rs.0.50 per share(50%)Final Dividend
View Bliss GVS Pharma Dividend History Arrow
Date Purpose Remarks
2008-03-18 Split Stock Split from Rs. 10/- to Re. 1/-.

Bliss GVS Pharma Shareholding Pattern

47.45%
35.01%
9.2%
8.07%
0.26%

About Bliss GVS Pharma

Bliss GVS Pharma is engaged in manufacturing, marketing, trading and export of pharmaceutical products. The Company is one of among the world leaders in Suppositories and Pessaries dosage forms with one of the largest portfolios in this segment. View More
  • NSE Symbol
  • BLISSGVS
  • BSE Symbol
  • 506197
  • ISIN
  • INE416D01022

Similar Stocks to Bliss GVS Pharma

Bliss GVS Pharma FAQs

Bliss GVS Pharma share price is ₹465 As on 01 August, 2026 | 03:23

The Market Cap of Bliss GVS Pharma is ₹4947.3 Cr As on 01 August, 2026 | 03:23

The P/E ratio of Bliss GVS Pharma is 38.3 As on 01 August, 2026 | 03:23

The PB ratio of Bliss GVS Pharma is 4.1 As on 01 August, 2026 | 03:23

The 52 week High & Low of Bliss GVS Pharma is ₹553/₹118 respectively As on 01 August, 2026 | 03:23

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23